What is 300676.SZ's gross margin?

BGI Genomics, (300676.SZ) has a gross margin of 39% and a net margin of 6%.

What is 300676.SZ's P/E ratio?

Track BGI Genomics, (300676.SZ) P/E ratio, ROE, and valuation metrics over time.

Where can I see 300676.SZ's full financials?

See BGI Genomics, (300676.SZ) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

BGI Genomics, (300676.SZ) Financials — Revenue, Earnings, Cash Flow

¥45.86 ($6.84)

+1.70 (+3.85%)

SHZ · Healthcare · Medical - Diagnostics & Research · Tech Score Buy · Power 64 · ¥19.2B mcap · 238M float · 4.02% daily turnover

Overview Chart Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ETF Exposure

📊 Key Metrics

TTM

¥4B

Revenue

+6.5% YoY

¥-575M

Net Income

+37.2% YoY

¥-351M

Free Cash Flow

+55.4% YoY

38.6%

Gross Margin

4.3%

Op. Margin

5.8%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-6.5%

ROA-4.8%

ROIC-7.4%

Valuation

P/E-33.3

P/B2.3

EV/EBITDA-48.6

Leverage

Debt/Equity0.07

Current Ratio2.81

Interest Cov.-15.7x

Quality Scores

Piotroski F4/9

Altman Z4.26

Beneish M-2.69